Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee

Lung Cancer

Volumn 85, Issue 1, 2014, Pages 74-80

  Califano, R ^a,b   Karamouzis, M V ^c   Banerjee, S ^d   de Azambuja, E ^e   Guarneri, V ^f   Hutka, M ^d   Jordan, K ^g   Kamposioras, K ^h   Martinelli, E ⁱ   Corral, J ^j   Postel Vinay, S ^k   Preusser, M ^l   Porcu, L ^m   Torri, V ^m  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e JULES BORDET INSTITUTE   (Belgium)

^f UNIVERSITY OF PADOVA   (Italy)

^g MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^h UNIVERSITY HOSPITAL OF LARISSA   (Greece)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k INSTITUT GUSTAVE ROUSSY   (France)

^l MEDICAL UNIVERSITY OF VIENNA   (Austria)

^m MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

more..

Author keywords

Adjuvant chemotherapy; Adjuvant radiotherapy; Incomplete resection; Non Small Cell Lung Cancer; R1; Survey

Indexed keywords

BEVACIZUMAB; CISPLATIN; ERLOTINIB; ETOPOSIDE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; OXALIPLATIN; PEMETREXED; PLATINUM;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL RESEARCH; CONSULTATION; FEMALE; HEALTH SURVEY; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDICAL ONCOLOGIST; ONCOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; WORKLOAD; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL PRACTICE; DECISION MAKING; EUROPE; LUNG NEOPLASMS; PATHOLOGY; PHYSICIAN; QUESTIONNAIRE;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; DECISION MAKING; EUROPE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICAL ONCOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT;

EID: 84901629344     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.03.010     Document Type: Article

References (16)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. Cancer J Clin 2013, 63:11-30.
2. Groome P.A., Bolejack V., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., Goldstraw P. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705.
3. Lim E., Harris G., Patel A., Adachi I., Edmonds L., Song F. Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials. J Thorac Oncol 2009, 4:1380-1388.
4. Vansteenkiste J., De Ruysscher D., Eberhardt W.E., Lim E., Senan S., Felip E., Peters S. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(Suppl. 6):vi89-vi98.
5. Pisters K.M.W., Evans W.K., Azzoli C.G., Kris M.G., Smith C.A., Desch C.E., Somerfield M.R., Brouwers M.C., Darling G., Ellis P.M., Gaspar L.E., Pass H.I., Spigel D.R., Strawn J.R., Ung Y.C., Shepherd F.A. Cancer care ontario and american society of clinical oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIa resectable non small-cell lung cancer guideline. J Clin Oncol 2007, 25:5506-5518.
6. Crino L., Weder W., van Meerbeeck J., Felip E. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl. 5):v103-v115.
7. Ghiribelli C., Voltolini L., Paladini P., Luzzi L., Di Bisceglie M., Gotti G. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. Eur J Cardiothorac Surg 1999, 16:555-559.
8. Soorae A.S., Stevenson H.M. Survival with residual tumor on the bronchial margin after resection for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1979, 78:175-180.
9. Gebitekin C., Gupta N.K., Satur C.M., Olgac G., Martin P.G., Saunders N.R., Walker D.R. Fate of patients with residual tumour at the bronchial resection margin. Eur J Cardiothorac Surg 1994, 8:339-342. discussion 342-334.
10. Massard G., Doddoli C., Gasser B., Ducrocq X., Kessler R., Schumacher C., Jung G.M., Wihlm J.M. Prognostic implications of a positive bronchial resection margin. Eur J Cardiothorac Surg 2000, 17:557-565.
11. Rami-Porta R., Mateu-Navarro M., Freixinet J., de la Torre M., Torres-Garcia A.J., Pun Y.W., Armengod A.C. Type of resection and prognosis in lung cancer. Experience of a multicentre study. Eur J Cardiothorac Surg 2005, 28:622-628.
12. Hothorn T., Hornik K., Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 2006, 15:651-674.
13. Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiother Oncol 2007, 83:203-213.
14. Kimura H., Yamaguchi Y. Survival of noncuratively resected lung cancer. Lung Cancer 1994, 11:229-242.
15. Heikkila L., Harjula A., Suomalainen R.J., Mattila P., Mattila S. Residual carcinoma in bronchial resection line. Ann Chir Gynaecol 1986, 75:151-154.
16. Kaiser L.R., Fleshner P., Keller S., Martini N. Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg 1989, 47:265-269.